Argent Biopharma Limited has released a press release.
Cimetra dose finding study approval
Filed with ASX · · 4 pages · English
6ix is checking which company filed this.
Story so far
Earlier from Argent Biopharma
- Response to ASX Query Letter
- AMC inc. places US$3M CimetrA purchase order
- First order received under US supply agreement
- ArtemiC eu sale approval and clinical trial update
- UK import permit granted for CannEpil
Later from Argent Biopharma
- Malta cimetra production facility update
- US Supply and Distribution Agreement Update
- Production Completed of A$1M ArtemiC Order from SPC
- UK Capital Raising Completed
- ArtemiC Long COVID Syndrome Clinical Study Commenced
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma